Oxford Immunotec, a Perkin Elmer company, received FDA approval to use T-Cell Select with its in vitro diagnostics tuberculosis (TB)...
News
Another gene therapy product has been added to the FDA-approved list: SKYSONA, a one-time gene therapy aimed to treat early,...
Good Therapeutics has entered into a merger agreement to be acquired by Roche to gain rights to the PD-1 regulated...
One serious complication of chemotherapy is the reduced neutrophil count 7 to 12 days post-treatment. Severe neutropenia is characterized by...
Around 160 million women worldwide use intrauterine devices (IUDs), according to an estimate from 2019. IUD is a T-shaped device...
Acute lymphoblastic leukemia (ALL) is a blood and bone marrow cancer occurring due to the abnormal proliferation of immature lymphocytes...
The FDA approved the Investigational New Drug application for initiating a Phase 1/2 clinical study of YH001 in combination with...
The FDA has granted breakthrough therapy designation to the ROS1 inhibitor taletrectinib for the treatment of patients with advanced or...
The FDA has granted approval for pemigatinib (Pemazyre) to treat adult patients with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) and...
Pediatric patients aged 1 year and above with chronic graft-versus-host disease (cGVHD) can now benefit from ibrutinib following the FDA...
